1
|
Miles SA, Nillama JA, Hunter L. Tinker, Tailor, Soldier, Spy: The Diverse Roles That Fluorine Can Play within Amino Acid Side Chains. Molecules 2023; 28:6192. [PMID: 37687021 PMCID: PMC10489206 DOI: 10.3390/molecules28176192] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2023] [Revised: 08/17/2023] [Accepted: 08/17/2023] [Indexed: 09/10/2023] Open
Abstract
Side chain-fluorinated amino acids are useful tools in medicinal chemistry and protein science. In this review, we outline some general strategies for incorporating fluorine atom(s) into amino acid side chains and for elaborating such building blocks into more complex fluorinated peptides and proteins. We then describe the diverse benefits that fluorine can offer when located within amino acid side chains, including enabling 19F NMR and 18F PET imaging applications, enhancing pharmacokinetic properties, controlling molecular conformation, and optimizing target-binding.
Collapse
Affiliation(s)
| | | | - Luke Hunter
- School of Chemistry, The University of New South Wales (UNSW), Sydney 2052, Australia
| |
Collapse
|
2
|
Sweetening Pharmaceutical Radiochemistry by 18F-Fluoroglycosylation: Recent Progress and Future Prospects. Pharmaceuticals (Basel) 2021; 14:ph14111175. [PMID: 34832957 PMCID: PMC8621802 DOI: 10.3390/ph14111175] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2021] [Revised: 11/11/2021] [Accepted: 11/15/2021] [Indexed: 12/11/2022] Open
Abstract
In the field of 18F-chemistry for the development of radiopharmaceuticals for positron emission tomography (PET), various labeling strategies by the use of prosthetic groups have been implemented, including chemoselective 18F-labeling of biomolecules. Among those, chemoselective 18F-fluoroglycosylation methods focus on the sweetening of pharmaceutical radiochemistry by offering a highly valuable tool for the synthesis of 18F-glycoconjugates with suitable in vivo properties for PET imaging studies. A previous review covered the various 18F-fluoroglycosylation methods that were developed and applied as of 2014 (Maschauer and Prante, BioMed. Res. Int. 2014, 214748). This paper is an updated review, providing the recent progress in 18F-fluoroglycosylation reactions and the preclinical application of 18F-glycoconjugates, including small molecules, peptides, and high-molecular-weight proteins.
Collapse
|
3
|
Linclau B, Ardá A, Reichardt NC, Sollogoub M, Unione L, Vincent SP, Jiménez-Barbero J. Fluorinated carbohydrates as chemical probes for molecular recognition studies. Current status and perspectives. Chem Soc Rev 2021; 49:3863-3888. [PMID: 32520059 DOI: 10.1039/c9cs00099b] [Citation(s) in RCA: 63] [Impact Index Per Article: 21.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
This review provides an extensive summary of the effects of carbohydrate fluorination with regard to changes in physical, chemical and biological properties with respect to regular saccharides. The specific structural, conformational, stability, reactivity and interaction features of fluorinated sugars are described, as well as their applications as probes and in chemical biology.
Collapse
Affiliation(s)
- Bruno Linclau
- School of Chemistry, University of Southampton, Highfield, Southampton SO171BJ, UK
| | - Ana Ardá
- CIC bioGUNE, Basque Research and Technology Alliance (BRTA), 48160 Derio, Spain.
| | | | - Matthieu Sollogoub
- Sorbonne Université, CNRS, Institut Parisien de Chimie Moléculaire, UMR 8232, 4 place Jussieu, 75005 Paris, France
| | - Luca Unione
- Department of Chemical Biology and Drug Discovery, Utrecht Institute for Pharmaceutical Science, Utrecht University, Universiteitsweg 99, 3584 CG, Utrecht, The Netherlands
| | - Stéphane P Vincent
- Department of Chemistry, Laboratory of Bio-organic Chemistry, University of Namur (UNamur), B-5000 Namur, Belgium
| | - Jesús Jiménez-Barbero
- CIC bioGUNE, Basque Research and Technology Alliance (BRTA), 48160 Derio, Spain. and Ikerbasque, Basque Foundation for Science, Maria Diaz de Haro 3, 48013 Bilbao, Spain and Department of Organic Chemistry II, Faculty of Science and Technology, UPV/EHU, 48940 Leioa, Spain
| |
Collapse
|
4
|
Liu W, Truillet C, Flavell RR, Brewer TF, Evans MJ, Wilson DM, Chang CJ. A reactivity-based [ 18F]FDG probe for in vivo formaldehyde imaging using positron emission tomography. Chem Sci 2016; 7:5503-5507. [PMID: 30034690 PMCID: PMC6021783 DOI: 10.1039/c6sc01503d] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2016] [Accepted: 05/04/2016] [Indexed: 12/11/2022] Open
Abstract
We present an aza-Cope-based reactivity probe for imaging formaldehyde in vivo using positron emission tomography.
Formaldehyde (FA) is a reactive carbonyl species (RCS) that plays a broad spectrum of roles in epigenetics, toxicology, and progression of diseases ranging from cancer to diabetes to neurodegeneration, motivating the development of translatable technologies for FA imaging. Here we report formaldehyde-caged-[18F]fluorodeoxyglucose-1 ([18F]FAC-FDG-1), an aza-Cope-based reactivity probe for in vivo FA imaging using positron emission tomography (PET). [18F]FAC-FDG-1 reacts selectively with FA over potentially competing analytes to generate [18F]FDG, allowing its FA-dependent uptake and retention in cell culture as well as in animal models. The relative uptake of [18F]FAC-FDG-1 was evaluated using FA-treated PC3 prostate cancer and U87-MG glioblastoma cells demonstrating a dose-dependent response to exogenously added FA. Moreover, [18F]FAC-FDG-1 is capable of FA detection in vivo using a PC3 tumor xenograft model. In addition to providing a unique tool for monitoring FA in living animals, these data establish a general approach for translatable detection of FA and other reactive biological analytes in vivo by exploiting the widely-available clinical [18F]FDG tracer as a masked aldehyde that can be caged by analyte-responsive triggers.
Collapse
Affiliation(s)
- Wei Liu
- Department of Chemistry , University of Berkeley , Berkeley , CA 94720 , USA . .,Department of Radiology and Biomedical Imaging , University of California , San Francisco , California 94158 , USA .
| | - Charles Truillet
- Department of Radiology and Biomedical Imaging , University of California , San Francisco , California 94158 , USA .
| | - Robert R Flavell
- Department of Radiology and Biomedical Imaging , University of California , San Francisco , California 94158 , USA .
| | - Thomas F Brewer
- Department of Chemistry , University of Berkeley , Berkeley , CA 94720 , USA .
| | - Michael J Evans
- Department of Radiology and Biomedical Imaging , University of California , San Francisco , California 94158 , USA .
| | - David M Wilson
- Department of Radiology and Biomedical Imaging , University of California , San Francisco , California 94158 , USA .
| | - Christopher J Chang
- Department of Chemistry , University of Berkeley , Berkeley , CA 94720 , USA . .,Department of Molecular and Cell Biology , University of California , Berkeley , California 94720 , USA.,Howard Hughes Medical Institute , University of California , Berkeley , California 94720 , USA
| |
Collapse
|
5
|
Collet C, Maskali F, Clément A, Chrétien F, Poussier S, Karcher G, Marie PY, Chapleur Y, Lamandé-Langle S. Development of 6-[18F]fluoro-carbohydrate-based prosthetic groups and their conjugation to peptides via click chemistry. J Labelled Comp Radiopharm 2015; 59:54-62. [DOI: 10.1002/jlcr.3362] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2015] [Revised: 11/20/2015] [Accepted: 11/23/2015] [Indexed: 12/27/2022]
Affiliation(s)
- Charlotte Collet
- Université de Lorraine; Vandoeuvre-les-Nancy France
- Nancyclotep, Plateforme d'imagerie moléculaire; Vandoeuvre-les-Nancy France
| | - Fatiha Maskali
- Nancyclotep, Plateforme d'imagerie moléculaire; Vandoeuvre-les-Nancy France
| | - Alexandra Clément
- Nancyclotep, Plateforme d'imagerie moléculaire; Vandoeuvre-les-Nancy France
| | - Françoise Chrétien
- Université de Lorraine; Vandoeuvre-les-Nancy France
- CNRS; UMR 7565; Vandoeuvre-les-Nancy France
| | - Sylvain Poussier
- Université de Lorraine; Vandoeuvre-les-Nancy France
- Nancyclotep, Plateforme d'imagerie moléculaire; Vandoeuvre-les-Nancy France
| | - Gilles Karcher
- Université de Lorraine; Vandoeuvre-les-Nancy France
- Nancyclotep, Plateforme d'imagerie moléculaire; Vandoeuvre-les-Nancy France
- Département de Médecine Nucléaire; CHU-Nancy; Vandoeuvre les Nancy France
| | - Pierre-Yves Marie
- Université de Lorraine; Vandoeuvre-les-Nancy France
- Nancyclotep, Plateforme d'imagerie moléculaire; Vandoeuvre-les-Nancy France
- Département de Médecine Nucléaire; CHU-Nancy; Vandoeuvre les Nancy France
| | - Yves Chapleur
- Université de Lorraine; Vandoeuvre-les-Nancy France
- Nancyclotep, Plateforme d'imagerie moléculaire; Vandoeuvre-les-Nancy France
- CNRS; UMR 7565; Vandoeuvre-les-Nancy France
| | - Sandrine Lamandé-Langle
- Université de Lorraine; Vandoeuvre-les-Nancy France
- CNRS; UMR 7565; Vandoeuvre-les-Nancy France
| |
Collapse
|
6
|
Flavell RR, Truillet C, Regan MK, Ganguly T, Blecha JE, Kurhanewicz J, VanBrocklin HF, Keshari KR, Chang CJ, Evans MJ, Wilson DM. Caged [(18)F]FDG Glycosylamines for Imaging Acidic Tumor Microenvironments Using Positron Emission Tomography. Bioconjug Chem 2015; 27:170-8. [PMID: 26649808 DOI: 10.1021/acs.bioconjchem.5b00584] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
Solid tumors are hypoxic with altered metabolism, resulting in secretion of acids into the extracellular matrix and lower relative pH, a feature associated with local invasion and metastasis. Therapeutic and diagnostic agents responsive to this microenvironment may improve tumor-specific delivery. Therefore, we pursued a general strategy whereby caged small-molecule drugs or imaging agents liberate their parent compounds in regions of low interstitial pH. In this manuscript, we present a new acid-labile prodrug method based on the glycosylamine linkage, and its application to a class of positron emission tomography (PET) imaging tracers, termed [(18)F]FDG amines. [(18)F]FDG amines operate via a proposed two-step mechanism, in which an acid-labile precursor decomposes to form the common radiotracer 2-deoxy-2-[(18)F]fluoro-d-glucose, which is subsequently accumulated by glucose avid cells. The rate of decomposition of [(18)F]FDG amines is tunable in a systematic fashion, tracking the pKa of the parent amine. In vivo, a 4-phenylbenzylamine [(18)F]FDG amine congener showed greater relative accumulation in tumors over benign tissue, which could be attenuated upon tumor alkalinization using previously validated models, including sodium bicarbonate treatment, or overexpression of carbonic anhydrase. This new class of PET tracer represents a viable approach for imaging acidic interstitial pH with potential for clinical translation.
Collapse
Affiliation(s)
- Robert R Flavell
- Department of Radiology and Biomedical Imaging, University of California , San Francisco, California 94158, United States
| | - Charles Truillet
- Department of Radiology and Biomedical Imaging, University of California , San Francisco, California 94158, United States
| | - Melanie K Regan
- Department of Radiology and Biomedical Imaging, University of California , San Francisco, California 94158, United States
| | - Tanushree Ganguly
- Department of Radiology and Biomedical Imaging, University of California , San Francisco, California 94158, United States
| | - Joseph E Blecha
- Department of Radiology and Biomedical Imaging, University of California , San Francisco, California 94158, United States
| | - John Kurhanewicz
- Department of Radiology and Biomedical Imaging, University of California , San Francisco, California 94158, United States
| | - Henry F VanBrocklin
- Department of Radiology and Biomedical Imaging, University of California , San Francisco, California 94158, United States
| | - Kayvan R Keshari
- Department of Radiology and Molecular Pharmacology and Chemistry Program, Memorial Sloan-Kettering Cancer Center , New York, New York 10065, United States
| | - Christopher J Chang
- Departments of Chemistry and Molecular and Cell Biology and the Howard Hughes Medical Institute, University of California , Berkeley, California 94720, United States
| | - Michael J Evans
- Department of Radiology and Biomedical Imaging, University of California , San Francisco, California 94158, United States
| | - David M Wilson
- Department of Radiology and Biomedical Imaging, University of California , San Francisco, California 94158, United States
| |
Collapse
|
7
|
AlJammaz I, Al-Otaibi B, AlHindas H, Okarvi SM. Novel synthesis and initial preclinical evaluation of (18)F-[FDG] labeled rhodamine: a potential PET myocardial perfusion imaging agent. Nucl Med Biol 2015; 42:804-8. [PMID: 26160144 DOI: 10.1016/j.nucmedbio.2015.06.009] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/08/2014] [Revised: 06/02/2015] [Accepted: 06/16/2015] [Indexed: 10/23/2022]
Abstract
Myocardial perfusion imaging is one of the most commonly performed investigations in nuclear medicine studies. Due to the clinical importance of [(18)F]-fluoro-2-deoxy-D-glucose ([(18)F]-FDG) and its availability in almost every PET center, a new radiofluorinated [(18)F]-FDG-rhodamine conjugate was synthesized using [(18)F]-FDG as a prosthetic group. In a convenient and simple one-step radiosynthesis, [(18)F]-FDG-rhodamine conjugate was prepared in quantitative radiochemical yields, with total synthesis time of nearly 20 min and radiochemical purity of greater than 98%, without the need for HPLC purification, which make these approaches amenable for automation. Biodistribution studies in normal rats at 60 min post-injection demonstrated a high uptake in the heart (>11% ID/g) and favorable pharmacokinetics. Additionally, [(18)F]-FDG-rhodamine showed an extraction value of 27.63%±5.12% in rat hearts. These results demonstrate that [(18)F]-FDG-rhodamine conjugate may be useful as an imaging agent for the positron emission tomography evaluation of myocardial perfusion.
Collapse
Affiliation(s)
- Ibrahim AlJammaz
- Cyclotron and Radiopharmaceuticals and Cell Biology Departments, King Faisal Specialist Hospital and Research Centre, P.O. Box 3354, Riyadh 11211, Kingdom of Saudi Arabia.
| | - Basim Al-Otaibi
- Cyclotron and Radiopharmaceuticals and Cell Biology Departments, King Faisal Specialist Hospital and Research Centre, P.O. Box 3354, Riyadh 11211, Kingdom of Saudi Arabia
| | - Hussein AlHindas
- Cyclotron and Radiopharmaceuticals and Cell Biology Departments, King Faisal Specialist Hospital and Research Centre, P.O. Box 3354, Riyadh 11211, Kingdom of Saudi Arabia
| | - Subhani M Okarvi
- Cyclotron and Radiopharmaceuticals and Cell Biology Departments, King Faisal Specialist Hospital and Research Centre, P.O. Box 3354, Riyadh 11211, Kingdom of Saudi Arabia
| |
Collapse
|
8
|
Sweetening pharmaceutical radiochemistry by (18)f-fluoroglycosylation: a short review. BIOMED RESEARCH INTERNATIONAL 2014; 2014:214748. [PMID: 24991541 PMCID: PMC4058687 DOI: 10.1155/2014/214748] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/19/2014] [Accepted: 04/15/2014] [Indexed: 12/20/2022]
Abstract
At the time when the highly efficient [(18)F]FDG synthesis was discovered by the use of the effective precursor 1,3,4,6-tetra-O-acetyl-2-O-trifluoromethanesulfonyl- β -D-mannopyranose (mannose triflate) for nucleophilic (18)F-substitution, the field of PET in nuclear medicine experienced a long-term boom. Thirty years later, various strategies for chemoselective (18)F-labeling of biomolecules have been developed, trying to keep up with the emerging field of radiopharmaceutical sciences. Among the new radiochemical strategies, chemoselective (18)F-fluoroglycosylation methods aim at the sweetening of pharmaceutical radiochemistry by providing a powerful and highly valuable tool for the design of (18)F-glycoconjugates with suitable in vivo properties for PET imaging studies. This paper provides a short review (reflecting the literature not older than 8 years) on the different (18)F-fluoroglycosylation reactions that have been applied to the development of various (18)F-glycoconjugate tracers, including not only peptides, but also nonpeptidic tracers and high-molecular-weight proteins.
Collapse
|
9
|
Ribeiro Morais G, Falconer RA, Santos I. Carbohydrate-Based Molecules for Molecular Imaging in Nuclear Medicine. European J Org Chem 2013. [DOI: 10.1002/ejoc.201201457] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
|
10
|
Al Jammaz I, Al-Otaibi B, Amer S, Al-Hokbany N, Okarvi S. Novel synthesis and preclinical evaluation of folic acid derivatives labeled with 18F-[FDG] for PET imaging of folate receptor-positive tumors. Nucl Med Biol 2012; 39:864-70. [DOI: 10.1016/j.nucmedbio.2012.02.005] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2011] [Revised: 01/18/2012] [Accepted: 02/18/2012] [Indexed: 10/28/2022]
|
11
|
Qi CM, He Y, Wang X, Feng M, Xu JL, Ding R, Liu H, Chen YR, Li F, Zhu ZH, Dang YH, Zhang ST, Xie Y. Synthesis and evaluation of N-(2-[18F]fluoro-4-nitrobenzoyl)glucosamine: a preliminary report. J Radioanal Nucl Chem 2011. [DOI: 10.1007/s10967-010-0935-4] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
12
|
Esmurziev AM, Simic N, Hoff BH, Sundby E. Synthesis and Structure Elucidation of Benzoylated Deoxyfluoropyranosides. J Carbohydr Chem 2010. [DOI: 10.1080/07328303.2010.540055] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
13
|
Maschauer S, Einsiedel J, Haubner R, Hocke C, Ocker M, Hübner H, Kuwert T, Gmeiner P, Prante O. Markierung und Glycosylierung von Peptiden mithilfe der Klick-Chemie: ein allgemeiner Ansatz zur Synthese von18F-Glycopeptiden, leistungsstarken Tracern für die Positronenemissionstomographie. Angew Chem Int Ed Engl 2010. [DOI: 10.1002/ange.200904137] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
14
|
Maschauer S, Einsiedel J, Haubner R, Hocke C, Ocker M, Hübner H, Kuwert T, Gmeiner P, Prante O. Labeling and Glycosylation of Peptides Using Click Chemistry: A General Approach to 18F-Glycopeptides as Effective Imaging Probes for Positron Emission Tomography. Angew Chem Int Ed Engl 2009; 49:976-9. [DOI: 10.1002/anie.200904137] [Citation(s) in RCA: 104] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
15
|
Maschauer S, Prante O. A series of 2-O-trifluoromethylsulfonyl-D-mannopyranosides as precursors for concomitant 18F-labeling and glycosylation by click chemistry. Carbohydr Res 2009; 344:753-61. [PMID: 19303067 DOI: 10.1016/j.carres.2009.02.001] [Citation(s) in RCA: 60] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2008] [Revised: 02/04/2009] [Accepted: 02/05/2009] [Indexed: 11/28/2022]
Abstract
A series of 'clickable' mannopyranosides bearing a triflate leaving group at C-2 position were synthesized and tested for their potential as (18)F-labeling precursors. 3,4,6-Tri-O-acetyl-2-O-trifluoromethanesulfonyl-beta-D-mannopyranosyl azide (2beta) was the most convenient precursor for a site-specific and reliable click chemistry-based three-step, two-pot concomitant (18)F-labeling and glycosylation of an alkyne-functionalized amino acid derivative.
Collapse
Affiliation(s)
- Simone Maschauer
- Laboratory of Molecular Imaging, Clinic of Nuclear Medicine, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany
| | | |
Collapse
|
16
|
Miller P, Long N, Vilar R, Gee A. Synthese von11C-,18F-,15O- und13N-Radiotracern für die Positronenemissionstomographie. Angew Chem Int Ed Engl 2008. [DOI: 10.1002/ange.200800222] [Citation(s) in RCA: 143] [Impact Index Per Article: 8.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
17
|
Miller P, Long N, Vilar R, Gee A. Synthesis of11C,18F,15O, and13N Radiolabels for Positron Emission Tomography. Angew Chem Int Ed Engl 2008; 47:8998-9033. [DOI: 10.1002/anie.200800222] [Citation(s) in RCA: 726] [Impact Index Per Article: 45.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
18
|
Wuest F, Berndt M, Bergmann R, van den Hoff J, Pietzsch J. Synthesis and application of [18F]FDG-maleimidehexyloxime ([18F]FDG-MHO): a [18F]FDG-based prosthetic group for the chemoselective 18F-labeling of peptides and proteins. Bioconjug Chem 2008; 19:1202-10. [PMID: 18481886 DOI: 10.1021/bc8000112] [Citation(s) in RCA: 73] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
2-[(18)F]Fluoro-2-deoxy-D-glucose ([(18)F]FDG) as the most important PET radiotracer is available in almost every PET center. However, there are only very few examples using [(18)F]FDG as a building block for the synthesis of (18)F-labeled compounds. The present study describes the use of [(18)F]FDG as a building block for the synthesis of (18)F-labeled peptides and proteins. [(18)F]FDG was converted into [(18)F]FDG-maleimidehexyloxime ([(18)F]FDG-MHO), a novel [(18)F]FDG-based prosthetic group for the mild and thiol group-specific (18)F labeling of peptides and proteins. The reaction was performed at 100 degrees C for 15 min in a sealed vial containing [(18)F]FDG and N-(6-aminoxy-hexyl)maleimide in 80% ethanol. [(18)F]FDG-MHO was obtained in 45-69% radiochemical yield (based upon [(18)F]FDG) after HPLC purification in a total synthesis time of 45 min. Chemoselecetive conjugation of [(18)F]FDG-MHO to thiol groups was investigated by the reaction with the tripeptide glutathione (GSH) and the single cysteine containing protein annexin A5 (anxA5). Radiolabeled annexin A5 ([(18)F]FDG-MHO-anxA5) was obtained in 43-58% radiochemical yield (based upon [(18)F]FDG-MHO, n = 6), and [(18)F]FDG-MHO-anxA5 was used for a pilot small animal PET study to assess in vivo biodistribution and kinetics in a HT-29 murine xenograft model.
Collapse
Affiliation(s)
- Frank Wuest
- Research Center Dresden-Rossendorf, Institute for Radiopharmacy, PF 510 119, D-01314 Dresden, Germany.
| | | | | | | | | |
Collapse
|
19
|
Prante O, Einsiedel J, Haubner R, Gmeiner P, Wester HJ, Kuwert T, Maschauer S. 3,4,6-Tri-O-acetyl-2-deoxy-2-[18F]fluoroglucopyranosyl phenylthiosulfonate: a thiol-reactive agent for the chemoselective 18F-glycosylation of peptides. Bioconjug Chem 2007; 18:254-62. [PMID: 17226980 DOI: 10.1021/bc060340v] [Citation(s) in RCA: 60] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
3,4,5-Tri-O-acetyl-2-[18F]fluoro-2-deoxy-d-glucopyranosyl 1-phenylthiosulfonate (Ac3-[18F]FGlc-PTS) was developed as a thiol-reactive labeling reagent for the site-specific 18F-glycosylation of peptides. Taking advantage of highly accessible 1,3,4,6-tetra-O-acetyl-2-deoxy-2-[18F]fluoroglucopyranose, a three-step radiochemical pathway was investigated and optimized, providing Ac3-[18F]FGlc-PTS in a radiochemical yield of about 33% in 90 min (decay-corrected and based on starting [18F]fluoride). Ac3-[18F]FGlc-PTS was reacted with the model pentapeptide CAKAY, confirming chemoselectivity and excellent conjugation yields of >90% under mild reaction conditions. The optimized method was adopted to the 18F-glycosylation of the alphavbeta3-affine peptide c(RGDfC), achieving high conjugation yields (95%, decay-corrected). The alphavbeta3 binding affinity of the glycosylated c(RGDfC) remained uninfluenced as determined by competition binding studies versus 125I-echistatin using both isolated alphavbeta3 and human umbilical vein endothelial cells (Ki = 68 +/- 10 nM (alphavbeta3) versus Ki = 77 +/- 4 nM (HUVEC)). The whole radiosynthetic procedure, including the preparation of the 18F-glycosylating reagent Ac3-[18F]FGlc-PTS, peptide ligation, and final HPLC purification, provided a decay-uncorrected radiochemical yield of 13% after a total synthesis time of 130 min. Ac3-[18F]FGlc-PTS represents a novel 18F-labeling reagent for the mild chemoselective 18F-glycosylation of peptides indicating its potential for the design and development of 18F-labeled bioactive S-glycopeptides suitable to study their pharmacokinetics in vivo by positron emission tomography (PET).
Collapse
Affiliation(s)
- Olaf Prante
- Laboratory of Molecular Imaging, Clinic of Nuclear Medicine, Friedrich-Alexander University, 91054 Erlangen, Germany.
| | | | | | | | | | | | | |
Collapse
|
20
|
Wester HJ, Schottelius M. Fluorine-18 labeling of peptides and proteins. ERNST SCHERING RESEARCH FOUNDATION WORKSHOP 2007:79-111. [PMID: 17172153 DOI: 10.1007/978-3-540-49527-7_4] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/13/2023]
Abstract
The pool of promising peptides worthy of investigation and evaluation for clinical use is continuously filled from different sources. Driven by the promising results obtained with peptides addressing somatostatin-2 receptor positive (sst2+) neuroendocrine tumours, other peptides targeting further receptor systems are being studied and evaluated. Progress in profiling the density and incidence of peptide hormone receptors in human cancer has initiated and will further promote research on the corresponding peptidic binders. In addition, industrial pharmaceutical research will be another significant source of peptides in the future. A recent prognosis revealed that about 50% of the drugs entering clinical trials in the next years will be peptides. The extensive research activities in genomics and proteomics will point out and quantify new and already known target structures upregulated in specific diseases. Based on the knowledge of their endogenous ligands or via selection of suitable candidates by phage display, suitable peptide ligands for e.g. membrane associated receptors can be identified and thus allow targeting of such binding sites. Thus, bioactive peptides specifically addressing relevant molecular targets are expected to become an important class of tracers, also due to the possibility of bridging imaging with therapeutic approaches. In this brief overview a summary of methods and strategies for the 18F-labeling of peptides and proteins is given.
Collapse
Affiliation(s)
- H J Wester
- Nuklearmedizinische Klinik und Poliklinik und Institut für Radiochemie, Technische Universität Müchen, Germany.
| | | |
Collapse
|
21
|
Prante O, Hamacher K, Coenen HH. Chemoenzymatic n.c.a synthesis of the coenzyme UDP-2-deoxy-2-[18F]fluoro-α-D-glucopyranose as substrate of glycosyltransferases. J Labelled Comp Radiopharm 2007. [DOI: 10.1002/jlcr.1161] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
22
|
Coenen HH. Fluorine-18 labeling methods: Features and possibilities of basic reactions. ERNST SCHERING RESEARCH FOUNDATION WORKSHOP 2007:15-50. [PMID: 17172151 DOI: 10.1007/978-3-540-49527-7_2] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/13/2023]
Abstract
Many experimental and established tracers make fluorine- 18 the most widely used radionuclide in positron emission tomography with an increasing demand for new or simpler 18F-labeling procedures. After a brief summary of the advantages of the nuclide and its major production routes, the basic features of the principal radiofluorination methods are described. These comprise direct electrophilic and nucleophilic processes, or in case of more complex molecules, the labeling of synthons and prosthetic groups for indirect built-up syntheses. While addressing the progress of no-carrier-added 18F-labeling procedures, the following chapters on more specific topics in this book are introduced. Emphasis is given to radiofluorination of arenes--especially with iodonium leaving groups. Examples of radiopharmaceutical syntheses are mentioned in order to illustrate strategic concepts of labeling with fluorine-18.
Collapse
Affiliation(s)
- H H Coenen
- Institut für Nuklearchemie, Forschungszentrum Jülich GmbH, Germany.
| |
Collapse
|
23
|
Maschauer S, Kuwert T, Prante O. 18F-glycosylation using Koenigs–Knorr conditions: a comparative study. J Labelled Comp Radiopharm 2006. [DOI: 10.1002/jlcr.1054] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|